Indications and Purposes
| Indications & Usage Section 1.1 Asthma Montelukast Sodium Tablet Is Indicated For The Prophylaxis And Chronic Treatment Of Asthma In Adults And Pediatric Patients 15 Years Of Age And Older. 1.2 Exercise-Induced Bronchoconstriction (Eib) Montelukast Sodium Tablet Is Indicated For Prevention Of Exercise-Induced Bronchoconstriction (Eib) In Patients 15 Years Of Age And Older. Pediatric Use Information For Patients Ages 6 To 14 Years Of Age For Acute Prevention Of Exercise-Induced Bronchoconstriction (Eib) Is Approved For Merck Sharp & Dohme Corp’s Montelukast Tablet Products. However, Due To Merck Sharp & Dohme Corp’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information. 1.3 Allergic Rhinitis Montelukast Sodium Tablet Is Indicated For The Relief Of Symptoms Of Seasonal Allergic Rhinitis In Patients 15 Years Of Age And Older And Perennial Allergic Rhinitis In Patients 15 Years Of Age And Older. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Montelukast Sodium |
|
ZINC3831151 |